Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 7.601\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a Cn1c2c(c(=O)n(C)c1=O)CN(CCc1ccccc1)CN2
b Cc1nnc(SCc2ccc(C(=O)Nc3cc(Cl)ccc3C)cc2)s1
Answer: b. Cc1nnc(SCc2ccc(C(=O)Nc3cc(Cl)ccc3C)cc2)s1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1nnc(SCc2ccc(C(=O)Nc3cc(Cl)ccc3C)cc2)s1
Cc1nnc(SCc2ccc(C(=O)Nc3cc(Cl)ccc3C)cc2)s1
N-(5-chloro-2-methylphenyl)-4-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]benzamide